Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Staiger

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.
Blood Advances|September 17, 2020
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk modelsStefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, et al.
Leukemia|August 30, 2023
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphomaFranziska Briest, Daniel Noerenberg, Cornelius Hennch, et al.
Blood|November 20, 2016
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphomaBeiying Dai, Michael Grau, Mélanie Juilland, et al.
Blood Advances|April 9, 2025
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potentialMiriam Verdú-Bou, Maria Joao Baptista, Marcelo Lima Ribeiro, et al.
Leukemia|August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease formsSabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2023
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient OutcomesDaniel Noerenberg, Franziska Briest, Cornelius Hennch, et al.
Blood Advances|February 24, 2026
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Kos, Evi Regitz, et al.
Blood Advances|December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Age Kos, Evi Regitz, et al.
Genes, Chromosomes & Cancer|January 23, 2025
MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q AberrationGioia Di Stefano, Anja Fischer, Emil Chteinberg, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.
Blood Advances|September 17, 2020
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk modelsStefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, et al.
Leukemia|August 30, 2023
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphomaFranziska Briest, Daniel Noerenberg, Cornelius Hennch, et al.
Blood|November 20, 2016
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphomaBeiying Dai, Michael Grau, Mélanie Juilland, et al.
Blood Advances|April 9, 2025
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potentialMiriam Verdú-Bou, Maria Joao Baptista, Marcelo Lima Ribeiro, et al.
Leukemia|August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease formsSabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2023
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient OutcomesDaniel Noerenberg, Franziska Briest, Cornelius Hennch, et al.
Blood Advances|February 24, 2026
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Kos, Evi Regitz, et al.
Blood Advances|December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Age Kos, Evi Regitz, et al.
Genes, Chromosomes & Cancer|January 23, 2025
MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q AberrationGioia Di Stefano, Anja Fischer, Emil Chteinberg, et al.
Pageof 7